Algorae Pharmaceuticals (ASX:1AI) Partners with Peter MacCallum Cancer Centre for AI-Driven Drug Screening
Algorae Pharmaceuticals (ASX:1AI) partners with Peter MacCallum Cancer Centre to validate AI-driven drug synergies in oncology.
Tag: Corporate Strategy & Guidance
Pro Medicus Limited (ASX:PME) Signs A$20M Contract with University of Iowa Health Care
Pro Medicus Limited (ASX:PME) signs a A$20M, 5-year contract with University of Iowa Health Care for its cloud-based Visage 7 platform.
Helloworld Travel Limited (ASX:HLO) Updates FY25 Guidance and Reports Strong Operational Performance
Helloworld Travel (ASX:HLO) revises FY25 UEBITDA guidance due to market volatility, while reporting strong operational performance.
Transurban Group (ASX:TCL) Announces Organisational Changes
Transurban Group (ASX:TCL) announces organisational changes to enhance efficiency and achieve over $50 million in cost savings.
Rimfire Pacific Mining (ASX:RIM) Reports Scandium Assay Results
Rimfire Pacific Mining (ASX:RIM) reports significant scandium intercepts from Currajong drilling, emphasizing strategic supply potential amid Chinese export restrictions.
Critical Resources Limited (ASX:CRR) Lodges Maiden Drilling Applications
Critical Resources (ASX:CRR) lodges first drilling applications for antimony-gold targets at Halls Peak Project, marking a significant exploration milestone.
SciDev Limited (ASX:SDV) Reports Q3 FY25 Financial Results
SciDev Limited (ASX:SDV) reports Q3 FY25 revenue up 10% and EBITDA up 200%, highlighting strategic expansion and new contracts.
Scentre Group (ASX:SCG) Reports Q1 2025 Operating Update
Scentre Group (ASX:SCG) reports a 2.8% sales increase in Q1 2025 and record annual sales, highlighting strong operational performance.
Tivan Limited (ASX:TVN) Announces Joint Venture with Sumitomo Corporation
Tivan Limited (ASX:TVN) partners with Sumitomo Corporation in a joint venture to develop the Speewah Fluorite Project, advancing Australia’s critical minerals sector.
MedAdvisor Limited (ASX:MDR) Implements Trading Halt Pending Acquisition Proposal
MedAdvisor Limited (ASX:MDR) places trading halt pending strategic acquisition proposal of ANZ business division.